Cargando…
Immunogenicity and safety of a live herpes zoster vaccine in hematopoietic stem cell transplant recipients
BACKGROUND: Herpes zoster (HZ) infection of hematopoietic stem cell transplant (HSCT) patients is of clinical concern. Vaccination could help restore immunity to varicella zoster virus (VZV); however, temporal changes in immunogenicity and safety of live HZ vaccines after HSCT is still unclear. The...
Autores principales: | Chun, June Young, Kim, Kichun, Lee, Min Kyeong, Kang, Chang Kyung, Koh, Youngil, Shin, Dong-Yeop, Hong, Junshik, Choe, Pyoeng Gyun, Kim, Nam Joong, Yoon, Sung-Soo, Park, Wan Beom, Kim, Inho, Oh, Myoung-don |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836155/ https://www.ncbi.nlm.nih.gov/pubmed/33499826 http://dx.doi.org/10.1186/s12879-021-05806-4 |
Ejemplares similares
-
Humoral and Cellular Immunogenicity of Zoster Vaccine within One Year after Herpes Zoster
por: Lee, Eunyoung, et al.
Publicado: (2017) -
The limited role of serum galactomannan assay in screening for invasive pulmonary aspergillosis in allogeneic stem cell transplantation recipients on micafungin prophylaxis: a retrospective study
por: Kim, Ryul, et al.
Publicado: (2017) -
Optimal Timing of Zoster Vaccination After Shingles: A Prospective Study of the Immunogenicity and Safety of Live Zoster Vaccine
por: Lee, Eunyoung, et al.
Publicado: (2018) -
Incidence of invasive fungal infection in acute lymphoblastic and acute myelogenous leukemia in the era of antimold prophylaxis
por: Oh, Sang-Min, et al.
Publicado: (2021) -
Limited Positive Predictive Value of β-d-Glucan in Hematologic Patients Receiving Antimold Prophylaxis
por: Chang, Euijin, et al.
Publicado: (2020)